Best of the Best Oral Presentation Clinical Oncology Society of Australia Annual Scientific Meeting 2020

Voluntary Assisted Dying (VAD) in Victoria: an audit of timings within the application process (#93)

Cameron McLaren 1 , Eva Segelov 1 , Eli Ristevski 2
  1. School of Clinical Sciences, Monash University, Clayton, VIC, 3806
  2. Rural & Indigenous Health, Monash University, Clayton, VIC, Australia

Introduction

The Voluntary Assisted Dying Act (2017) (The Act) came into effect on 19th June 2019. The process of application is: First Request, Coordinating Assessment, Consulting Assessment, Written Declaration, approval of a VAD permit, and medication delivery. Anecdotally, many applicants do not complete the process. I In the first six months of operation,136 patients applied for VAD, with one-year data released in August 2020. Analysing timeline data may assist in understanding factors relating to provision of this service and monitor for delays that may impede patients’ access to this end-of-life option.

Methods

An audit of the first 50 patients with cancer assessed by author (CM) for eligibility to access VAD was conducted. Definitions were used as per The Act. Data was analysed according to whether the process was “completed” (received VAD medication) or “withdrawn” (not received VAD medication). The date of First Request was coded as day 1, from which subsequent milestones were timed (Table 1).  Reasons for withdrawal were categorised.

Results

Of the first 50 patients assessed, 32 were completed. All of the 18 withdrawn cases died during the application process: 2 prior to Consulting Assessment; 6 prior to Written Declaration; 6 prior to Permit Approval; and 4 prior to Medication Delivery.

Table 1: Timing of each application step

 

Days: mean (range)

Timepoint

Completed

Withdrawn

All

Coordinating Assessment

19 (1-255)

13 (1-83)

17 (1-255)

Consulting Assessment

27 (1-261)

19 (3-91)

24 (1-261)

Written Declaration

32 (2-261)

29 (6-97)

32 (2-261)

Permit Approval

37 (4-263)

44 (13-98)

38 (4-263)

Medication Delivery

47 (3-269)

N/A

46 (3-269)

Administration or Death

58 (4-270)

26 (4-100)

45 (4-270)

 

Conclusion

The time to complete the various stages varied widely. In this cohort, there was no obvious difference between completed and withdrawn cases.  Ongoing data collection will allow further analysis by demographic and tumour factors.